OKTA vs TECH · P/E 84, rev $2.61B vs P/E 65, rev $1.22B
Okta Inc (OKTA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported OKTA revenue for 2025-01-31 was $2.61B. Net income was $28.0M. Revenue was up 15.3% from 2024-01-31 to 2025-01-31. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the OKTA and TECH stock pages for the full models.
Not investment advice.